A broad study into inflammatory substances in the blood of COVID-19 patients supports the hypothesis that kinins could play a role in the severe respiratory problems experienced by critically ill COVID-19 patients in intensive care. This is a third pathway, in addition to the massive infection of lung cells and the limited production of white blood cells, that could underly the symptoms of such patients. This discovery, published at MedRxiv by researchers from Radboud university medical Center, could lead to the accelerated development of new treatments.
In most people, a SARS-CoV-2 infection causes mild respiratory symptoms. But in 10 to 15 percent of those infected, it leads to pneumonia and ARDS (acute respiratory distress syndrome), where inflammation disrupts the usual immune response, causing an almost unstoppable ‘hyper-inflammation’. To date, no comprehensive hypothesis has explained exactly how this life-threatening inflammatory process proceeds.
Image of biomarkersTo gain more insight into that process, researchers from Radboud university medical center and their Dutch colleagues looked at the blood of COVID-19 patients to identify substances that play an essential role in immunological and inflammatory processes. The presence or absence of such substances (biomarkers) can provide a good indication of what is happening in the body. They therefore analyzed biomarkers from 119 patients, 38 of whom were in the ICU and 89 in regular wards.
Corona patients in the ICU“For example, we looked at various interleukins, which we know play an important role in those processes,” says internist Frank van de Veerdonk. “But if you want to detect unknown processes, you also have to search without bias for other substances that may be important. That is why we searched very broadly with a technique called targeted proteomics and analyzed all that data using a systems biology approach. This provided an excellent overview of the immunological and inflammatory processes that take place in the patients. The important question was then: do we see differences in biomarkers between the patients in the regular wards and the seriously ill patients in the ICU?”
Pathogenic mechanismThe answer was ‘yes’. For example, in IC patients, the researchers found increased concentrations of interleukin 6 (IL-6), various chemokines, hepatocyte growth factor and various components of the complement system. In contrast, the concentrations of stem cell factor, DPP4 and protein C inhibitor were substantially lower in ICU patients. These data point to an overarching pathogenic mechanism that appears in almost all critically ill COVID-19 patients.
Three pathways to disease developmentIn any case, the researchers see three clear pathways to the development of the disease (see illustration). The infection pathway, in which the SARS-CoV-19 virus infects more and more cells, has been previously described. The other two pathways are less well known. The observed decrease in stem cell factor (SCF) is directly related to a lower production of white blood cells. It is known that a shortage of white blood cells increases mortality risk.
Leaking blood vessels
The third pathway is directly related to the phenomenon that many COVID-19 patients describe as acute breathing difficulty due to the sudden ‘filling of the lungs’. Researchers at Radboud university medical center previously hypothesized that the local disappearance of ACE2 (angiotensin-converting enzyme 2) on lung cells due to the massive virus infection would make the blood vessels leak. They published that hypothesis in the article Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome in the journal eLife
The idea is that ACE2 plays a role not only in regulating blood pressure throughout the body, but also in regulating the amount of kinins. Without that regulation, kinins are given free rein and cause leakage in the small blood vessels in the lungs. “The decrease in biomarkers such as DPP4 and protein C inhibitor that we found in our study supports our hypothesis,” said internist Mihai Netea. “Both substances play a role in the kallikrein-kinin system (KKS), which makes it plausible that this pathway also plays an important role in the disease process. Our findings make it possible to accelerate the development of new treatments for this group of COVID-19 patients.”
-MedRxiv: A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection - Frank L. van de Veerdonk, Nico A.F. Janssen, Inge Grondman, Aline H. de Nooijer, Valerie A.C.M. Koeken, Vasiliki Matzaraki, Collins K. Boahen, Vinod Kumar, Matthijs Kox, Prof Hans J.P.M. Koenen, Ruben L. Smeets, Prof Irma Joosten, Roger J.M. Brüggemann, Ilse J.E. Kouijzer, Prof Hans G. van der Hoeven, Jeroen A. Schouten, Tim Frenzel, Monique Reijers, Wouter Hoefsloot, Anton S.M. Dofferhoff, Angèle P.M. Kerckhoffs, Marc J.T. Blaauw, Karin Veerman, Coen Maas, Arjan H.
Related news items
Software for ranking protein-protein interfaces Released by eScience Center10 July 2020
Li Xue of the CMBI contributed to the development of a software package that ranks and scores protein-protein interfaces (PPIs). This article was published in Software X.read more
Research Integrity Round 16 September 2020 Sex and gender and research integrity: a tale of how and who9 July 2020
Topic of this webinar is sex and gender in (bio)medical research. Speakers are dean Prof. Jan Smit, Prof. Sabine Oertelt–Prigione and Prof. Hanneke Takkenberg (ErasmusMC). All junior and senior researchers are invited to join the discussion. Please register via the website.read more
Finally, an explanation for hearing loss in twelve Dutch families9 July 2020
The culprit is a genetic abnormality, a discovery that immediately makes it one of the most common causes of hereditary hearing loss in the Netherlands.read more
Rebecca Halbach receives idea generator grant to fight mosquito transmitted viruses8 July 2020
Rebecca Halbach and Pascal Miesen have investigated in a collaborative project whether the treatment of mosquitoes with antiviral drugs can prevent the transmission of mosquito-transmitted viral diseases.read more
Invasive fungal infections in influenza and COVID-198 July 2020
The Aspergillus fungus is found in the lungs of many COVID patients. A parallel occurs with influenza patients, who often develop a serious fungal infection. Although such a serious fungal infection seems to occur less frequently in COVID-patients, alertness remains necessary,read more